Cytomegalovirus (CMV) anticorps

N° du produit ABIN3026155

Détail du produit

Antigène: Cytomegalovirus (CMV)

Reactivité: Cytomegalovirus (CMV)

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Inconjugué

Application: Immunofluorescence (IF), ELISA, Immunocytochemistry (ICC)

Purification: Protein G purified CMV antibody

Clone: CMV100

Isotype: IgG1 kappa

Information d'application

Indications d'application: The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the CMV antibody to be titered up or down for optimal performance.\. ELISA: order BSA-free CMV antibody format for coating,Immunocytochemistry (Acetone or paraformaldehyde fixed) 0.5-1 μg/mL for 30 min,IF: 0.5-1 μg/mL

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: 4 °C,-20 °C

Stockage commentaire: Store the CMV antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).

Détail du antigène

Antigène: Cytomegalovirus (CMV)

Autre désignation: CMV Cytomegalovirus (CMV Produits)

Synonymes: anticorps CMVFR, anticorps transmembrane anterior posterior transformation 1, anticorps TAPT1

Classe de substances: Virus

Sujet: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.